Osteopontin: A novel axon‐regulated Schwann cell gene
- 14 December 2001
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 67 (2) , 156-166
- https://doi.org/10.1002/jnr.10099
Abstract
Osteopontin (OPN) is a RGD‐containing glycoprotein with cytokine‐like, chemotactic, and pro‐adhesive properties. During wound healing, OPN is abundantly expressed by infiltrating macrophages and has been implicated in posttraumatic tissue repair. To delineate a role in the regenerative response to axotomy we examined the expression of OPN in Wallerian degeneration of the sciatic nerve in rats. Unexpectedly, we found high constitutive expression of OPN by myelinating Schwann cells (SCs) in uninjured control nerves. OPN mRNA expression was confirmed in primary cultures of rat SCs. Upon axotomy, SC‐expressed OPN in the degenerating distal nerve stump transiently increased during the first days after injury, but was continuously downregulated thereafter, reaching its minimum at Day 14. Macrophages invading axotomized nerves were OPN‐negative. During late stages after axotomy, SC‐OPN was reexpressed in regenerating but not permanently transected nerves. We also found OPN expression by myelinating SCs in human sural nerves with a dramatic reduction in severe axonal polyneuropathies. Taken together, our study identifies OPN as a novel Schwann cell gene regulated by axon‐derived signals. The lack of OPN induction in infiltrating macrophages indicates fundamental differences in tissue repair between axonal injury in the peripheral nervous system and structural lesions in other organ systems.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (Sto 162/8-1)
This publication has 47 references indexed in Scilit:
- Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) ImmunityScience, 2000
- Osteopontin and its Integrin Receptor α v β 3 Are Upregulated During Formation of the Glial Scar After Focal StrokeStroke, 1998
- Altered wound healing in mice lacking a functional osteopontin gene (spp1).Journal of Clinical Investigation, 1998
- Osteopontin Expression in Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cells and Carotid Artery After Balloon AngioplastyArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)Science, 1996
- The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro.Journal of Clinical Investigation, 1995
- Coexpression of PMP22 gene with MBP and P0 during de novo myelination and nerve repairGlia, 1993
- The effects of cAMP on differentiation of cultured Schwann cells: progression from an early phenotype (04+) to a myelin phenotype (P0+, GFAP-, N-CAM-, NGF-receptor-) depends on growth inhibition.The Journal of cell biology, 1991
- Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradationJournal of Neurocytology, 1989
- The role of non-resident cells in Wallerian degenerationJournal of Neurocytology, 1984